{"url_path":"/sec/pbm/10-k/2026/item-16c","section_key":"item-16c","section_title":"Item 16C PRINCIPAL ACCOUNTANT FEES AND SERVICES","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1985062/0001213900-26-070607-index.html","accession_number":"0001213900-26-070607","cik":"0001985062","ticker":"PBM","issuer_name":"PSYENCE BIOMEDICAL LTD.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1985062/0001213900-26-070607-index.html","primary_entity_key":"0001985062","primary_entity_name":"PSYENCE BIOMEDICAL LTD."},"word_count":116,"has_tables":true,"body_markdown":"ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES\n\n \n\nThe aggregate fees billed by the Company’s\nexternal auditors in each of the last two fiscal years are as follows.\n\n \n\n  \nMarch 31,\n2026  \nMarch 31,\n2025 \n\nAudit fees \n$158,926  \n$152,253 \n\nAudit-related fees \n$-  \n$— \n\nTax fees \n$-  \n$— \n\nAll other fees \n$-  \n$— \n\nTotal \n$158,926  \n$152,253 \n\n** **\n\n**Notes:**\n\n \n\nThe policy of the Company’s Audit Committee\nis to pre-approve all audit and non-audit services provided by MNP LLP, its current independent registered public accounting firm, including\naudit services, audit-related services, tax services, and other services as described above. Pursuant to this policy, the Audit Committee\npre-approved all of the services provided to us by MNP during the year since the Closing."}